503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.36%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
0.12%
Cost growth less than half of CRWD's 7.31%. David Dodd would verify if cost advantage is structural.
-14.80%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
-3.88%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-5.17%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
-0.79%
G&A reduction while CRWD shows 7.72% growth. Joel Greenblatt would examine efficiency advantage.
-22.11%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
20.96%
Other expenses change of 20.96% while CRWD maintains costs. Bruce Berkowitz would investigate efficiency.
-13.03%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-8.34%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-10.92%
Both companies reducing D&A. Martin Whitman would check industry patterns.
238.44%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
-6.69%
Both companies show margin pressure. Martin Whitman would check industry conditions.
2664.58%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
3018.79%
Operating margin growth exceeding 1.5x CRWD's 14.45%. David Dodd would verify competitive advantages.
35.33%
Other expenses growth above 1.5x CRWD's 18.80%. Michael Burry would check for concerning trends.
1441.50%
Pre-tax income growth exceeding 1.5x CRWD's 20.26%. David Dodd would verify competitive advantages.
1639.01%
Pre-tax margin growth exceeding 1.5x CRWD's 24.73%. David Dodd would verify competitive advantages.
25.50%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
1007.72%
Net income growth exceeding 1.5x CRWD's 29.52%. David Dodd would verify competitive advantages.
1124.02%
Net margin growth exceeding 1.5x CRWD's 33.47%. David Dodd would verify competitive advantages.
1002.90%
EPS growth exceeding 1.5x CRWD's 29.55%. David Dodd would verify competitive advantages.
1002.90%
Diluted EPS growth exceeding 1.5x CRWD's 29.55%. David Dodd would verify competitive advantages.
0.10%
Share count reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.
1.26%
Diluted share reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.